↓ Skip to main content
AI Standard of Care
  1. Tags/

Drug Discovery

AI in Pharmaceutical Drug Discovery Liability

··15 mins
Industries Pharmaceutical AI Drug Discovery FDA Guidance EU AI Act Clinical Trials AI Bias Product Liability AlphaFold
AI in Drug Discovery: The New Liability Frontier # Artificial intelligence is transforming pharmaceutical development at unprecedented scale. The AI drug discovery market has grown to approximately $2.5-7 billion in 2025, with projections reaching $16-134 billion by 2034 depending on the analysis. AI-discovered molecules reportedly achieve an 80-90% success rate in Phase I trials, substantially higher than traditional discovery methods.